These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 7700045)

  • 21. The role of vascular endothelial growth factor in peritoneal hyperpermeability during CAPD-related peritonitis.
    Szeto CC; Wong TY; Lai KB; Chow KM; Li PK
    Perit Dial Int; 2002; 22(2):265-7. PubMed ID: 11990414
    [No Abstract]   [Full Text] [Related]  

  • 22. Sclerosing encapsulating peritonitis in children.
    Niaudet P; Berard E; Revillon Y; Lothon M; Broyer M
    Contrib Nephrol; 1987; 57():230-8. PubMed ID: 3677698
    [No Abstract]   [Full Text] [Related]  

  • 23. Persistent transforming growth factor beta 1 expression may predict peritoneal fibrosis in CAPD patients with frequent peritonitis occurrence.
    Lin CY; Chen WP; Fu LW; Yang LY; Huang TP
    Adv Perit Dial; 1997; 13():64-71. PubMed ID: 9360653
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunophenotyping by flow cytometry of peritoneal fluid of patients with peritonitis on continuous ambulatory peritoneal dialysis.
    Enríquez J; Klínger J; Arturo JA; Tobar C; Ceballos O
    Adv Perit Dial; 2002; 18():184-7. PubMed ID: 12402615
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Peritoneal macrophage heterogeneity is associated with different peritoneal dialysis outcomes.
    Liao CT; Andrews R; Wallace LE; Khan MW; Kift-Morgan A; Topley N; Fraser DJ; Taylor PR
    Kidney Int; 2017 May; 91(5):1088-1103. PubMed ID: 28065517
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The role of cytokines in peritoneal dialysis].
    Opatrná S; Topolcan O; Opatrný K
    Vnitr Lek; 2000 Nov; 46(11):794-800. PubMed ID: 15637896
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Involvement of TGF-beta signal for peritoneal sclerosing in continuous ambulatory peritoneal dialysis.
    Naiki Y; Maeda Y; Matsuo K; Yonekawa S; Sakaguchi M; Iwamoto I; Hasegawa H; Kanamaru A
    J Nephrol; 2003; 16(1):95-102. PubMed ID: 12649540
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recovery of gastrointestinal function after renal transplantation in patients with sclerosing peritonitis secondary to continuous ambulatory peritoneal dialysis.
    Bhandari S
    Am J Kidney Dis; 1996 Apr; 27(4):604. PubMed ID: 8678075
    [No Abstract]   [Full Text] [Related]  

  • 29. The long-term effects of single peritonitis episodes on peritoneal equilibration test results in continuous ambulatory peritoneal dialysis patients.
    Hung SY; Chung HM
    Adv Perit Dial; 2001; 17():196-9. PubMed ID: 11510273
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Changes in the phagocytic cells in children treated with continuous ambulatory peritoneal dialysis.
    Wasik M; Blaim M; Kolewska D; Janota-Krawczyk E; Tomaszewska-Pańczyk M; Sieniawska M
    Arch Immunol Ther Exp (Warsz); 1997; 45(2-3):189-94. PubMed ID: 9597086
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sclerosing peritonitis.
    Bowers VD; Ackermann JR; Richardson W; Carey LC
    Clin Transplant; 1994 Aug; 8(4):369-72. PubMed ID: 7949541
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Automated peritoneal dialysis: impact on residual kidney function and peritoneal membrane permeability].
    Gallar P; Ortega O; Gutiérrez M; Carreño A; Domínguez-Gil B; Hilara L; Oliet A; Rodríguez I; Giménez E; Vigil A
    Nefrologia; 2001; 21(2):200-3. PubMed ID: 11464654
    [No Abstract]   [Full Text] [Related]  

  • 33. The histophysiology and pathophysiology of the peritoneum.
    van Baal JO; Van de Vijver KK; Nieuwland R; van Noorden CJ; van Driel WJ; Sturk A; Kenter GG; Rikkert LG; Lok CA
    Tissue Cell; 2017 Feb; 49(1):95-105. PubMed ID: 27890350
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The cytokine network controlling peritoneal inflammation.
    Topley N
    Perit Dial Int; 1995; 15(7 Suppl):S35-9; discussion S39-40. PubMed ID: 8555324
    [No Abstract]   [Full Text] [Related]  

  • 35. Changes in the peritoneal interstitium and their effect on peritoneal transport.
    Flessner MF
    Perit Dial Int; 1999; 19 Suppl 2():S77-82. PubMed ID: 10406498
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Host defense mechanisms involved in peritonitis.
    Lewis SL; Holmes CJ
    Perit Dial Int; 1993; 13 Suppl 2():S295-8. PubMed ID: 8399592
    [No Abstract]   [Full Text] [Related]  

  • 37. Peritoneal immune defense in continuous ambulatory peritoneal dialysis: clinical relevance and practical implications.
    Holmes CJ
    Perit Dial Int; 1993; 13 Suppl 2():S278-81. PubMed ID: 8399588
    [No Abstract]   [Full Text] [Related]  

  • 38. [The pathophysiological bases of peritonitis therapy].
    Berger D; Beger HG
    Chirurg; 1992 Mar; 63(3):147-52. PubMed ID: 1559396
    [No Abstract]   [Full Text] [Related]  

  • 39. Peritoneal ultrastructure and changes with continuous ambulatory peritoneal dialysis.
    Dobbie JW
    Perit Dial Int; 1993; 13 Suppl 2():S585-7. PubMed ID: 8399672
    [No Abstract]   [Full Text] [Related]  

  • 40. Preserving the peritoneum in CAPD.
    Medcalf JF; Harris K; Walls J
    Nephrol Dial Transplant; 1997 Mar; 12(3):393-5. PubMed ID: 9075114
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.